Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase

doi:10.1084/jem.142.4.856

This Article

Full Text (PDF)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JEM

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Fearon, D. T.

Articles by Austen, K. F.

Search for Related Content

PubMed

PubMed Citation

Articles by Fearon, D. T.

Articles by Austen, K. F.

Pubmed/NCBI databases

Substance via MeSH

Social Bookmarking

What's this?

ARTICLES

Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase

DT Fearon and KF Austen

A function of P in the alternative complement pathway is to prolong the first order decay of the hemolytic sites on EAC43B in a dose-dependent manner. As the number of initial convertase sites is not changed, even when activated properdin (P) increases the t1/2 10-fold or more, P acts to stabilize rather than to uncover additional sites. P binds to EAC43 to generate EAC43P in a reaction that proceeds slightly more rapidly at 15 degrees C than at 0 degrees C, but reaches the same plateau and does not require divalent cations. The presence of P on EAC43P not only stabilizes the convertase subsequently formed on that cell, but, alternatively, permits transfer to convertase sites on other cells with the stability of the recipient intermediate being dependent on the P available for transfer. The capacity of P to bind to C3b and stabilize C3B contrasts with the inhibitory effect of the C3b inactivator on formation of this amplification convertase.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Kemper, C., Mitchell, L. M., Zhang, L., Hourcade, D. E. (2008). The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis. Proc. Natl. Acad. Sci. USA 105: 9023-9028 [Abstract] [Full Text]
Xu, W., Berger, S. P., Trouw, L. A., de Boer, H. C., Schlagwein, N., Mutsaers, C., Daha, M. R., van Kooten, C. (2008). Properdin Binds to Late Apoptotic and Necrotic Cells Independently of C3b and Regulates Alternative Pathway Complement Activation. J. Immunol. 180: 7613-7621 [Abstract] [Full Text]
Tyson, K. R., Elkins, C., de Silva, A. M. (2008). A Novel Mechanism of Complement Inhibition Unmasked by a Tick Salivary Protein That Binds to Properdin. J. Immunol. 180: 3964-3968 [Abstract] [Full Text]
Kimura, Y., Miwa, T., Zhou, L., Song, W.-C. (2008). Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement. Blood 111: 732-740 [Abstract] [Full Text]
Spitzer, D., Mitchell, L. M., Atkinson, J. P., Hourcade, D. E. (2007). Properdin Can Initiate Complement Activation by Binding Specific Target Surfaces and Providing a Platform for De Novo Convertase Assembly. J. Immunol. 179: 2600-2608 [Abstract] [Full Text]
Hourcade, D. E. (2006). The Role of Properdin in the Assembly of the Alternative Pathway C3 Convertases of Complement. J. Biol. Chem. 281: 2128-2132 [Abstract] [Full Text]
Kolln, J., Spillner, E., Andra, J., Klensang, K., Bredehorst, R. (2004). Complement Inactivation by Recombinant Human C3 Derivatives. J. Immunol. 173: 5540-5545 [Abstract] [Full Text]
Chong, A. J., Hampton, C. R., Verrier, E. D. (2003). Microvascular Inflammatory Response in Cardiac Surgery. SEMIN CARDIOTHORAC VASC ANESTH 7: 333-354 [Abstract]
Hellwage, J., Jokiranta, T. S., Friese, M. A., Wolk, T. U., Kampen, E., Zipfel, P. F., Meri, S. (2002). Complement C3b/C3d and Cell Surface Polyanions Are Recognized by Overlapping Binding Sites on the Most Carboxyl-Terminal Domain of Complement Factor H. J. Immunol. 169: 6935-6944 [Abstract] [Full Text]
Bjerketorp, J., Nilsson, M., Ljungh, A., Flock, J.-I., Jacobsson, K., Frykberg, L. (2002). A novel von Willebrand factor binding protein expressed by Staphylococcus aureus. Microbiology 148: 2037-2044 [Abstract] [Full Text]
Boffa, M. B., Bell, R., Stevens, W. K., Nesheim, M. E. (2000). Roles of Thermal Instability and Proteolytic Cleavage in Regulation of Activated Thrombin-activable Fibrinolysis Inhibitor. J. Biol. Chem. 275: 12868-12878 [Abstract] [Full Text]
Makrides, S. C. (1998). Therapeutic Inhibition of the Complement System. Pharmacol. Rev. 50: 59-88 [Abstract] [Full Text]
Weisman, H., Bartow, T, Leppo, M., Marsh, H. Jr, Carson, G., Concino, M., Boyle, M., Roux, K., Weisfeldt, M., Fearon, D. (1990). Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249: 146-151 [Abstract]
Theofilopoulos, A., Perrin, L. (1977). Lysis of human cultured lymphoblastoid cells by cell-induced activation of the properdin pathway. Science 195: 878-880 [Abstract]
Whaley, K, Ruddy, S (1976). Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator. Science 193: 1011-1013 [Abstract]
Hartmann, S., Hofsteenge, J. (2000). Properdin, the Positive Regulator of Complement, Is Highly C-Mannosylated. J. Biol. Chem. 275: 28569-28574 [Abstract] [Full Text]
Jokiranta, T. S., Hellwage, J., Koistinen, V., Zipfel, P. F., Meri, S. (2000). Each of the Three Binding Sites on Complement Factor H Interacts with a Distinct Site on C3b. J. Biol. Chem. 275: 27657-27662 [Abstract] [Full Text]